StockData
AbbVie Inc. logo

AbbVie Inc.

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$288.84−6.05 (-2.05%)

Close on Nov 2, 2026Market cap $510.41BP/E 81.6Yield 2.30%

AbbVie Total Net Revenues — United States by Year

Total Net Revenues — United States ($M) ($M)

AbbVie Total Net Revenues — United States: $46,603M in FY2025, up 8.3% from a year earlier. That is the highest of the 11 years on record here.

Latest, FY2025
46,603
Period ended Dec 31, 2025
Change on a year earlier
+8.3%
43,029 in FY2024
History
11 years
Since FY2015
Sources
11
Documents cited below

Where the FY2025 figure comes from

“|| NET REVENUES | $ | 46,603 | $ | 14,557 | $ | 61,160 | 8.3% | 9.4% | 8.6% | 9.2% | 8.5%”

Source: Form 8-K (abbv-20251231xexhibit991.htm, filed 2026-02-04) ↗

Reported in Form 8-K Key Product Revenues & Form 10-K Segment Note.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal Net Revenues — United States ($M) ($M)Year on yearSource
FY2025Dec 31, 202546,603+8.3%Form 8-K (abbv-20251231xexhibit991.htm, filed 2026-02-04) ↗
FY2024Dec 31, 202443,029+2.7%Form 8-K (abbv-20241231xexhibit991.htm, filed 2025-01-31) ↗
FY2023Dec 31, 202341,883-8.4%Form 8-K (abbv-20231231xexhibit991.htm, filed 2024-02-02) ↗
FY2022Dec 31, 202245,713+5.1%Form 8-K (abbv-20221231xexhibit991.htm, filed 2023-02-09) ↗
FY2021Dec 31, 202143,510+24.7%Form 10-K (filed 2024-02-20) ↗
FY2020Dec 31, 202034,879+45.9%Form 10-K (filed 2023-02-17) ↗
FY2019Dec 31, 201923,907+11.1%Form 10-K (filed 2022-02-18) ↗
FY2018Dec 31, 201821,524+17.9%Form 10-K (filed 2021-02-19) ↗
FY2017Dec 31, 201718,251+14.4%Form 10-K (filed 2020-02-21) ↗
FY2016Dec 31, 201615,947+17.6%Form 10-K (filed 2019-02-27) ↗
FY2015Dec 31, 201513,561–Form 10-K (filed 2018-02-16) ↗

Breakdown

What makes up total Net Revenues — United States

Cite this data

StockData. (2026). AbbVie Total Net Revenues — United States ($M), annual FY2015–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/rev-total-us

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.